Volume 12, number 1
 Views: (Visited 71 times, 1 visits today)    PDF Downloads: 965

Montayeva N. S, Kushaliyev K. Z, Shalmenov M, Gusmanov M. G, Sadenov M. M. Haematological, Biochemical and Immunomorphologic Changes in dogs with Melanoma and Melanocytoma. Biosci Biotech Res Asia 2015;12(1)
Manuscript received on : 
Manuscript accepted on : 
Published online on:  01-02-2016
How to Cite    |   Publication History    |   PlumX Article Matrix

Haematological, Biochemical and Immunomorphologic Changes in dogs with Melanoma and Melanocytoma

Nurgul Sarsenbekovna Montayeva, Kaisar Zhalitovich Kushaliyev, Malik Shalmenov, Makhambet Ginayatovich Gusmanov and Marat Myrzabekovich Sadenov

West-Kazakhstan Agrarian-Technical University Named After Zhangir Khan, The Republic of Kazakhstan, 090009, Uralsk, Zhangir Khan Street, 51, Russia.

ABSTRACT: The purpose of this study is to analyze the disease incidence in dogs with melanoma and melanocytoma living in the territory of Uralsk. Dogs with neoplastic diseases of the skin were objects of research. Predominant localization of tumors in dogs, were observed in the mouth cavity. Mostly male dogs aged 9 to 12 years came down with melanoma and melanocytoma. Among the diseased purebred dogs the golden retrievers were encountered most of all.

KEYWORDS: Melanoma; tumor; melanocytoma; dogs

Download this article as: 
Copy the following to cite this article:

Montayeva N. S, Kushaliyev K. Z, Shalmenov M, Gusmanov M. G, Sadenov M. M. Haematological, Biochemical and Immunomorphologic Changes in dogs with Melanoma and Melanocytoma. Biosci Biotech Res Asia 2015;12(1)

Copy the following to cite this URL:

Montayeva N. S, Kushaliyev K. Z, Shalmenov M, Gusmanov M. G, Sadenov M. M. Haematological, Biochemical and Immunomorphologic Changes in dogs with Melanoma and Melanocytoma. Biosci Biotech Res Asia 2015;12(1). Available from: https://www.biotech-asia.org/?p=5636>

(Visited 71 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.